Global Cancer Diagnostics Patent Landscape Analysis 2024: By Product: Solid Consumables and Instruments, By Technology: Positron Emission Tomography (PET), Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Magnetic Resonance Spectroscopy (MRS), Multi-Parameter Flow Cytometry, Immunohistochemistry, Microarray and Next Generation Sequencing (NGS); Key Player Profiles

1    Introduction
2    Executive Summary
3    Global Cancer Diagnostics Market Overview 
    3.1    Global Cancer Diagnostics Market Historical Value (2017-2023) 
    3.2    Global Cancer Diagnostics Market Forecast Value (2024-2032)
4    Global Cancer Diagnostics Market Segmentation 
    4.1    Global Cancer Diagnostics Market Share by Product
        4.1.1    Market Overview
        4.1.2    Consumables
            4.1.2.1    Antibodies
            4.1.2.2    Reagents
            4.1.2.3    Probes
            4.1.2.4    Others
        4.1.3    Instrument
            4.1.3.1    Pathology Instrument
            4.1.3.2    Imaging Instrument
            4.1.3.3    Others
    4.2    Global Cancer Diagnostics Market Share by Indication
        4.2.1    Market Overview
        4.2.2    Breast Cancer
        4.2.3    Lung Cancer
        4.2.4    Colorectal Cancer
        4.2.5    Brain Tumor
        4.2.6    Blood Cancer
        4.2.7    Others 
    4.3    Global Cancer Diagnostics Market Share by End User
        4.3.1    Market Overview
        4.3.2    Hospital
        4.3.3    Diagnostic Laboratory
        4.3.4    Research Centre
5    Global Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    Porter’s Five Forces Analysis
    5.3    PESTEL Analysis 
    5.4    Industry Events, Initiatives, and Trends  
    5.5    Value Chain Analysis
6    Global Cancer  Diagnostics Patent Landscape Analysis
    6.1    Patent Distribution by Publication Year
    6.2    Patent Distribution by Application Year
    6.3    Patent Distribution by Priority Year
    6.4     Analysis by Type of Patent
        6.4.1    Granted Patents 
        6.4.2    Patent Application
        6.4.3    Amended Application
        6.4.4    Search Report
    6.5    Analysis by Legal Status
        6.5.1    Active 
        6.5.2    Pending 
        6.5.3    Expired/Discontinued 
    6.6    Analysis by Patent Jurisdiction
    6.7    Analysis by Patent Age
    6.8    Analysis by Cooperative Patent Classification (CPC) Codes
    6.9    Average Time to Publish a Patent
        6.9.1    By Entities
        6.9.2    By Jurisdiction
        6.9.3    By Technology
    6.10    Analysis by Type of Entity (Academic and Non-Academic)
    6.11    Analysis by Top Applicants
    6.12    Analysis by Top Inventors
7    Global Cancer Diagnostics Patent Analysis by Technology
    7.1    Total Patents by Top Technologies 
    7.2    Time Evolution of Patents by Technology
    7.3    Emerging Technologies
    7.4    Medical imaging
        7.4.1    Time Evolution by Number of Patents
        7.4.2    Time Evolution by Number of Patent Families
        7.4.3    Analysis by Type of Entity (Academic vs Non-Academic)
        7.4.4    Analysis by Top Applicants
        7.4.5    Analysis by Top Inventors
    7.5    AI-based tool
        7.5.1    Time Evolution by Number of Patents
        7.5.2    Time Evolution by Number of Patent Families
        7.5.3    Analysis by Type of Entity (Academic vs Non-Academic)
        7.5.4    Analysis by Top Applicants
        7.5.5    Analysis by Top Inventors
    7.6    Lab-on-chip
        7.6.1    Time Evolution by Number of Patents
        7.6.2    Time Evolution by Number of Patent Families
        7.6.3    Analysis by Type of Entity (Academic vs Non-Academic)
        7.6.4    Analysis by Top Applicants
        7.6.5    Analysis by Top Inventors
    7.7    Liquid biopsy
        7.7.1    Time Evolution by Number of Patents
        7.7.2    Time Evolution by Number of Patent Families
        7.7.3    Analysis by Type of Entity (Academic vs Non-Academic)
        7.7.4    Analysis by Top Applicants
        7.7.5    Analysis by Top Inventors
*Complete technology list will be provided in the report.
8    EMR Patent Valuation Analysis
    8.1    Assessment Methodology
    8.2    High Value Patents
    8.3    Medium Value Patents
    8.4    Low Value Patents
9    Global Cancer Diagnostics – Top 10 Players Patent Analysis 
    9.1    Top 10 Entities by Number of Patents
    9.2    Analysis by Publication Year
    9.3    Analysis by Application Year
    9.4    Analysis by Priority Year
    9.5    Analysis by Type of Patent
    9.6    Analysis by Jurisdiction
    9.7    Analysis by Cooperative Patent Classification (CPC) Codes
    9.8    Analysis by Source of Innovation 
    9.9    Analysis by Forward and Backward Citations
    9.10    Analysis by Legal Status
    9.11    Analysis by Patent Age
    9.12    Analysis by Key Inventors
    9.13    Entity Dynamics
        9.13.1    Analysis by Type of Player (Academic vs Non-Academic)
        9.13.2    Analysis by Collaboration 
        9.13.3    Analysis by Technology
        9.13.4    Newcomers 
            9.13.4.1    Start-up Companies
            9.13.4.2    Established Companies
10    Patent Profile of Key Players
    10.1    GE HealthCare Technologies, Inc . 
        10.1.1    Product Portfolio
        10.1.2    Patent Portfolio by Patent Families
        10.1.3    Time Evolution of Patents
        10.1.4    Geographical Patent Coverage 
        10.1.5    Patent Analysis by Technology
        10.1.6    Patent News and Developments
        10.1.7    Financial Analysis
        10.1.8    SWOT Analysis
    10.2    Abbott Laboratories 
    10.3    F. Hoffmann-La Roche Ltd 
    10.4    Qiagen N.V .
    10.5    Becton Dickinson & Company 
11    Future Trends
12    Global Cancer Diagnostics Market Landscape (Additional Insight)* 
    12.1    Global Cancer Diagnostics: Developers Landscape
        12.1.1    Analysis by Year of Establishment
        12.1.2    Analysis by Company Size
        12.1.3    Analysis by Region
    12.2    Global Cancer Diagnostics: Product Landscape 
        12.2.1    Analysis by Product Type
        12.2.2    Analysis by Technology
        12.2.3    Analysis by Application

*Additional insights are not provided in the standard report.